Molecular Biology of Huntington's Disease

被引:0
|
作者
Ersoy, Nagehan [1 ]
Basak, A. Nazli [1 ]
机构
[1] Bogazici Univ, Mol Biyol & Genet Bolumu, TR-34342 Bebek, Turkey
关键词
Huntington's Disease; polyglutamine diseases; CAG repeats; neurodegeneration;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Huntington's Disease ( HD) is the most common among nine known polyglutamine disorders. Its prevalence is estimated to be 3-7/100 000 in populations of Western European descent. HD is an autosomal dominantly inherited neurodegenerative disorder of the central nervous system, characterized by involuntary movements, impaired motor coordination, cognitive loss and various psychiatric abnormalities. The most prominent pathological finding is the selective neuron death in basal ganglia. The disease gene ( IT-15), localized to chromosome 4 in 1993 and 180kb long, is composed of 67 exons. The gene product is a 348 kDa protein, called huntingtin, whose function is not known yet. The mutation causing HD is the expansion of the CAG triplet repeat in the first exon of the IT-15 gene. Huntington's Disease Working Group has identified four repeat intervals: People who carry 26 or less CAG repeats in the IT-15 gene are healthy, alleles with 27-35 repeats may show intergenerational instability, people carrying 36-39 CAG repeats may or may not develop the disease, however 40 or more CAG repeats definitely cause HD, if people live long enough. The molecular diagnosis of HD with direct mutation analysis has been available since 1993. In this method, the CAG repeat region on the IT15 gene is PCR-amplified, and the repeat number is determined using radioactive
引用
收藏
页码:27 / 44
页数:16
相关论文
共 50 条
  • [1] The molecular biology of Huntington's disease
    Ho, LW
    Carmichael, J
    Swartz, J
    Wyttenbach, A
    Rankin, J
    Rubinsztein, DC
    [J]. PSYCHOLOGICAL MEDICINE, 2001, 31 (01) : 3 - 14
  • [2] Huntington disease: Advances in molecular and cell biology
    Jones, AL
    Wood, JD
    Harper, PS
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 1997, 20 (02) : 125 - 138
  • [3] The molecular biology of Huntington's disease or in science curiosity pays - At least sometimes
    Perutz, MF
    [J]. USEFUL KNOWLEDGE: THE AMERICAN PHILOSOPHICAL SOCIETY MILLENNIUM PROGRAM, 1999, 234 : 59 - 68
  • [4] Schizophrenia and Huntington's disease. Clinical and molecular biology data in French families
    Luaute, JP
    Turpin, JC
    Lucotte, G
    [J]. SEMAINE DES HOPITAUX, 1997, 73 (15-16): : 480 - 486
  • [5] Molecular aspects of Huntington's disease
    Walling, HW
    Baldassare, JJ
    Westfall, TC
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 1998, 54 (03) : 301 - 308
  • [6] Molecular basis for Huntington's disease
    不详
    [J]. CHEMICAL & ENGINEERING NEWS, 1997, 75 (37) : 25 - 25
  • [7] Molecular Imaging in Huntington's Disease
    Wilson, Heather
    Politis, Marios
    [J]. IMAGING IN MOVEMENT DISORDERS: IMAGING IN ATYPICAL PARKINSONISM AND FAMILIAL MOVEMENT DISORDERS, 2018, 142 : 289 - 333
  • [8] Molecular Pathogenesis in Huntington’s Disease
    S. N. Illarioshkin
    S. A. Klyushnikov
    V. A. Vigont
    Yu. A. Seliverstov
    E. V. Kaznacheyeva
    [J]. Biochemistry (Moscow), 2018, 83 : 1030 - 1039
  • [9] Molecular diagnosis in Huntington's disease
    Alejandra Rosales-Reynoso, Mnica
    Barros-Nunez, Patricio
    [J]. GACETA MEDICA DE MEXICO, 2008, 144 (03): : 271 - 273
  • [10] Molecular Genetics of Huntington's Disease
    Bobori, Catherine
    [J]. GENEDIS 2014: NEURODEGENERATION, 2015, 822 : 59 - 65